Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Cabometyx |
| Active Ingredient: | Cabozantinib s-malate 25.34mg equivalent to cabozantinib 20mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
| Manufacturer: | Patheon Inc, Mississauga, Ontario, Canada |
| Product: | Cabometyx |
| Active Ingredient: | Cabozantinib s-malate 50.69mg equivalent to cabozantinib 40mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
| Manufacturer: | Patheon Inc, Mississauga, Canada |
| Product: | Cabometyx |
| Active Ingredient: | Cabozantinib s-malate 76.03mg equivalent to cabozantinib 60mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
| Manufacturer: | Patheon Inc, Mississauga, Canada |
| Product: | Chlorvescent |
| Active Ingredients: | Potassium bicarbonate 384mg Potassium carbonate 152mg Potassium chloride 595mg |
| Dosage Form: | Effervescent tablet |
| New Zealand Sponsor: | Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
| Manufacturer: | SwissCo Services AG, Sisseln, Switzerland |
| Product: | Lynparza |
| Active Ingredient: | Olaparib 100mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | AstraZeneca Limited |
| Manufacturers: | AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany AbbVie Limited, Barceloneta, Puerto Rico AstraZeneca AB, Sodertalje, Sweden |
| Product: | Lynparza |
| Active Ingredient: | Olaparib 150mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | AstraZeneca Limited |
| Manufacturers: | AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany AbbVie Limited, Barceloneta, Puerto Rico AstraZeneca AB, Sodertalje, Sweden |
| Product: | Nurofen for Children 5-12 Years Orange Flavour |
| Active Ingredient: | Ibuprofen 40mg/mL |
| Dosage Form: | Oral suspension |
| New Zealand Sponsor: | Reckitt Benckiser (New Zealand) Limited |
| Manufacturer: | Reckitt Benckiser Healthcare (UK) Limited, Hull, United Kingdom |
| Product: | Nurofen for Children 5-12 Years Strawberry Flavour |
| Active Ingredient: | Ibuprofen 40mg/mL |
| Dosage Form: | Oral suspension |
| New Zealand Sponsor: | Reckitt Benckiser (New Zealand) Limited |
| Manufacturer: | Reckitt Benckiser Healthcare (UK) Limited, Hull, United Kingdom |
Dated this 22nd day of June 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).